Antoine Legras
Prof Antoine Legras is an expert in Pulmonology at Centre Hospitalier Universitaire de Tours (France). Antoine Legras has authored 86 publications, the most recent in 2026, and is an investigator in 2 clinical trials, 1 of them ongoing. SLR score: 239 (community average: 125). How the SLR is computed.
LeadR Profile
Pulmonology
Subspecialties: Oncology - Public Health
Main Topics
Publications and Clinical Studies
Profile data updated on
Expert Rankings
Top experts on the MeSH terms this expert works on
Organizations
Career arc: 1991 - 2026
Number : 86
Citations
Main journals
Best Journals
Breakdown by type
Click a legend label to hide or show it in the chart.
Latest Publications
5 most recent indexed articles
Source: Pubmed
| Title | Journal | Year | Citations |
|---|---|---|---|
| Necrosis of the diaphragm pleural empyema and pneumomediastinum as rare complications of appendicitis: A case report. PMID 42058320 — thoracotomy, thoracoscopy, empyema, empyema, pleural, mediastinal emphysema, necrosis, diaphragm, appendicitis | IDCases | 2026 | 0 |
| Cis-aconitate therapy protects against influenza mortality by dual targeting of viral polymerase and ERK/AKT/NF-κB signaling. PMID 41699259 — mortality, aconitic acid, influenza, human, therapeutics, antiviral agents | EMBO Mol Med | 2026 | 0 |
| Infectious morbi-mortality in thoracic surgery after major resections. PMID 40809222 — thoracotomy, amoxicillin-potassium clavulanate combination, mortality, thoracic surgery, incidence, antibiotic prophylaxis, amoxicillin, air, pneumonia, risk factors, clavulanic acid, therapeutics, bacteria | J Thorac Dis | 2025 | 1 |
| Uncertain Resection in Lung Cancer: A Comprehensive Review of the International Association for the Study of Lung Cancer Classification. PMID 40361313 — lung, neoplasms, classification, drug therapy, lung neoplasms, prognosis, chemotherapy | Cancers (Basel) | 2025 | 0 |
| From tissue to subcellular level : imaging human precision-cut lung slices (PCLS) to gain insight into pandemic bacterial or viral infections OpenAlex W4402257978 — sars-cov-2, lung, pandemics, tissues, infections, virus diseases | bioRxiv (Cold Spring Harbor Laboratory) | 2024 | 0 |
Clinical Studies 2
Synthesis
By phase:
By status:
By type:
By Monocentric/Multicentric:
Main Topics
Ongoing Clinical Trials
Ongoing trial started since 2021, where this expert is an investigator
Source: ClinicalTrials
| Study | Phase | Status | Start |
|---|---|---|---|
| Molecular Signature From Tumor to Lymph Nodes NCT04677205 — lung, lymph nodes, neoplasms, carcinoma, non-small-cell lung, drug therapy, lung neoplasms, lymph, tissues, prognosis, chemotherapy | N/A | Recruiting | 2021 |
LeadR Networks
Main global connection map